TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 88 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $6,857,000 | +5614.2% | 390,496 | +3055.0% | 0.00% | – |
| Q2 2021 | $120,000 | +252.9% | 12,377 | +291.3% | 0.00% | – |
| Q1 2021 | $34,000 | +1033.3% | 3,163 | +1505.6% | 0.00% | – |
| Q4 2020 | $3,000 | -99.9% | 197 | -99.9% | 0.00% | -100.0% |
| Q3 2020 | $4,964,000 | +26.7% | 349,300 | -27.9% | 0.00% | 0.0% |
| Q2 2020 | $3,917,000 | +639.1% | 484,239 | +269.2% | 0.00% | – |
| Q1 2020 | $530,000 | +597.4% | 131,170 | +1149.2% | 0.00% | – |
| Q4 2017 | $76,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |